A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 20. 11. 2019, under the no. SUKLS401789/2017 - The appeal is dismissed and the decision under appeal is upheld
More information: MZCR.cz (czech version only)